Serum N-acetylaspartate level in amyotrophic lateral sclerosis

Archives of Neurology

Volumn 68, Issue 10, 2011, Pages 1306-1310

  Simone, Isabella L ^a   Ruggieri, Maddalena ^a   Tortelli, Rosanna ^a   Ceci, Edmondo ^a   D'Errico, Eustachio ^a   Leo, Antonio ^a   Zoccolella, Stefano ^a   Mastrapasqua, Mariangela ^a   Capozzo, Rosa ^a   Livrea, Paolo ^a   Logroscino, Giancarlo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; N ACETYLASPARTIC ACID; RILUZOLE;

ADULT; AGE; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; ITALY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 80053892763     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.217     Document Type: Article

References (40)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688-1700. (Pubitemid 32479968)
2. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007;81(2):89-131. (Pubitemid 46282272)
3. Baslow MH, Suckow RF, Sapirstein V, Hungund BL. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J Mol Neurosci. 1999;13(1-2):47-53. (Pubitemid 30101999)
4. Clark JB. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci. 1998;20(4-5):271-276.
5. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res. 2003;28(6):941-953. (Pubitemid 36438413)
6. Kelley RI, Stamas JN. Quantification of N-acetyl-L-aspartic acid in urine by isotope dilution gas chromatography-mass spectrometry. J Inherit Metab Dis. 1992;15(1):97-104.
7. Hagenfeldt L, Bollgren I, Venizelos N. N-acetylaspartic aciduria due to aspartoacylase deficiency: a new aetiology of childhood leukodystrophy. J Inherit Metab Dis. 1987;10(2):135-141. (Pubitemid 17128224)
8. Sijens PE, Oudkerk M, de Leeuw FE, et al. 1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men. Magn Reson Med. 1999;42(1):24-31. (Pubitemid 29325609)
9. Charles HC, Lazeyras F, Krishnan KR, et al. Proton spectroscopy of human brain: effects of age and sex. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18(6):995-1004. (Pubitemid 24279582)
10. Jaarsma D, Veenma-van der Duin L, Korf J. N-acetylaspartate and Nacetylaspartylglutamate levels in Alzheimer's disease post-mortem brain tissue. J Neurol Sci. 1994;127(2):230-233. (Pubitemid 24380171)
11. Schuff N, Capizzano AA, Du AT, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology. 2002;58(6):928-935. (Pubitemid 34242070)
12. Federico F, Simone IL, Lucivero V, et al. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders. Mov Disord. 1997;12(6):903-909. (Pubitemid 27496766)
13. Simone IL, Tortorella C, Federico F, et al. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. J Neurol Sci. 2001;182(2):143-150. (Pubitemid 33786711)
14. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N- acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology. 1998;50(6):1800-1805. (Pubitemid 28283255)
15. Ellis CM, Simmons A, Jones DK, et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology. 1999;53(5):1051-1058. (Pubitemid 29442122)
16. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology. 2001;43(3):189-197.
17. Sivák S, Bittšanský M, Kurča E, et al. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology. 2010;52(12):1079-1085.
18. Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SCR, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology. 1998;51(4):1104-1109. (Pubitemid 28473408)
19. Pohl C, Block W, Karitzky J, et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol. 2001;58(5):729-735. (Pubitemid 32423044)
20. Kaufmann P, Pullman SL, Shungu DC, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology. 2004;62(10):1753-1757. (Pubitemid 38661730)
21. Rothstein JD, Tsai G, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990;28(1):18-25. (Pubitemid 20222147)
22. Tortorella C, Ruggieri M, Dimonte E, et al. Serum and CSF N-acetyl-aspartate (NAA) levels differ in multiple sclerosis and neuromyelitis optica [published ahead of print May 27, 2011]. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp.2011.241836.
23. Jasperse B, Jakobs C, Eikelenboom MJ, et al. N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry. J Neurol. 2007;254(5):631-637. (Pubitemid 46781977)
24. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299.
25. Zoccolella S, Beghi E, Palagano G, et al SLAP Registry. Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur J Neurol. 2006;13(7):789-792. (Pubitemid 44139382)
26. Zoccolella S, Beghi E, Palagano G, et al. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci. 2008;268(1-2):28-32. (Pubitemid 351395319)
27. Great Lakes ALS Study Group. A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis. Neurology. 2003;61(11):1503-1507.
28. Cedarbaum JM, Stambler N, Malta E, et al BDNF ALS Study Group (Phase III). The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1-2):13-21. (Pubitemid 29502501)
29. Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66(2):265-267. (Pubitemid 43970171)
30. Ruggieri M, Tortorella C, Ceci E, et al. Age-related changes of serum N-acetylaspartate in healthy controls. Age Ageing. 2011;40(3):391-395.
31. Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem. 2001;78(4):736-745. (Pubitemid 32777975)
32. Sager TN, Thomsen C, Valsborg JS, Laursen H, Hansen AJ. Astroglia contain a specific transport mechanism for N-acetyl-L-aspartate. J Neurochem. 1999;73(2):807-811. (Pubitemid 29339856)
33. Stevens H, Jakobs C, de Jager AEJ, Cunningham RT, Korf J. Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke. Eur J Clin Invest. 1999;29(1):6-11. (Pubitemid 29084242)
34. Teunissen CE, Iacobaeus E, Khademi M, et al. Combination of CSF Nacetylaspartate and neurofilaments in multiple sclerosis. Neurology. 2009;72(15):1322-1329.
35. Kadota T, Horinouchi T, Kuroda C. Development and aging of the cerebrum: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol. 2001;22(1):128-135. (Pubitemid 32105365)
36. Pan JW, Takahashi K. Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain. Ann Neurol. 2005;57(1):92-97. (Pubitemid 40053319)
37. Househam E, Swash M. Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement? J Neurol Sci. 2000;180(1-2):76-81.
38. Chiò A, Logroscino G, Hardiman O, et al Eurals Consortium. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5-6):310-323.
39. Kalra S, Tai P, Genge A, Arnold DL. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. J Neurol. 2006;253(8):1060-1063. (Pubitemid 44441132)
40. Arun P, Moffett JR, Namboodiri AMA. Riluzole decreases synthesis of N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells. Brain Res. 2010;1334:25-30.